Effectiveness Or Bust: Without Benefit, No Case For Keeping Makena On The Market, CDER Says

 
• By Sue Sutter
Makena hearing and driving risks
FDA's Christine Nguyen aimed to center efficacy in the discussion by noting that everything involves risks, and people wouldn't drive cars unless it got them somewhere. • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards